Cargando…

Metagenomic profiling reveals dominance of gram‐positive bacteria in the gut microbiome shifts associated with immunoglobulin A vasculitis (Henoch–Schönlein Purpura)

OBJECTIVES: Immunoglobulin A vasculitis (IgAV), previously known as Henoch–Schönlein purpura, is the most common vasculitis that has a classical skin manifestation of palpable purpuric rash. Factors pertinent to IgAV remain inadequately understood. Here, we aimed to examine the gut microbiome shifts...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Jia, Wu, Chunyan, Wang, Kunhua, Hu, Hongwei, Duan, Jiang, Zhao, Bo, Xiong, Jingjing, Liu, Mei, Cui, Jingjing, Ji, Xiaofei, Zhang, Tingting, Qin, Huanlong, Qin, Nan, Xu, Qian, Huang, Yongkun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499602/
https://www.ncbi.nlm.nih.gov/pubmed/34646556
http://dx.doi.org/10.1002/cti2.1342
_version_ 1784580342964813824
author Cao, Jia
Wu, Chunyan
Wang, Kunhua
Hu, Hongwei
Duan, Jiang
Zhao, Bo
Xiong, Jingjing
Liu, Mei
Cui, Jingjing
Ji, Xiaofei
Zhang, Tingting
Qin, Huanlong
Qin, Nan
Xu, Qian
Huang, Yongkun
author_facet Cao, Jia
Wu, Chunyan
Wang, Kunhua
Hu, Hongwei
Duan, Jiang
Zhao, Bo
Xiong, Jingjing
Liu, Mei
Cui, Jingjing
Ji, Xiaofei
Zhang, Tingting
Qin, Huanlong
Qin, Nan
Xu, Qian
Huang, Yongkun
author_sort Cao, Jia
collection PubMed
description OBJECTIVES: Immunoglobulin A vasculitis (IgAV), previously known as Henoch–Schönlein purpura, is the most common vasculitis that has a classical skin manifestation of palpable purpuric rash. Factors pertinent to IgAV remain inadequately understood. Here, we aimed to examine the gut microbiome shifts associated with IgAV and its recovery. METHODS: Stool samples were collected from 10 children with IgAV (6–14 years old) before and after a multi‐drug therapy, along with 9 age‐matched healthy children. The samples were subjected to metagenomic analyses to investigate the taxonomic and functional shifts of the gut microbiome. RESULTS: The analyses revealed that compared with healthy controls, treatment‐naïve patients exhibited substantial taxonomic and functional alterations of gut microbiota, including 104 IgAV‐depleted species and 7 IgAV‐elevated species (FDR < 0.05). After treatment, the IgAV patients displayed a partial restoration of the microbiota shifts, as the relative abundances of some biomarkers (e.g. 9 genera and 22 species) became comparable (FDR > 0.1) between the patients and healthy controls. The treatment‐responsive features included Weissella, Faecalibacterium prausnitzii and Bifidobacterium pseudocatenulatum and three components of a putative glutamine transport system. Importantly, gram‐positive bacteria accounted for over 85% of the numbers and total relative abundance of the species that were associated with IgAV and responsive to the treatment. In addition, of the 122 IgAV‐depleted bacterial genes, 82 were mainly contributed by gram‐positive bacteria and 12 by gram‐negative bacteria. CONCLUSIONS: Gram‐positive bacteria are the main drivers underlying the gut microbiome shifts of IgAV, which may assist rational management of the disease.
format Online
Article
Text
id pubmed-8499602
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84996022021-10-12 Metagenomic profiling reveals dominance of gram‐positive bacteria in the gut microbiome shifts associated with immunoglobulin A vasculitis (Henoch–Schönlein Purpura) Cao, Jia Wu, Chunyan Wang, Kunhua Hu, Hongwei Duan, Jiang Zhao, Bo Xiong, Jingjing Liu, Mei Cui, Jingjing Ji, Xiaofei Zhang, Tingting Qin, Huanlong Qin, Nan Xu, Qian Huang, Yongkun Clin Transl Immunology Short Communication OBJECTIVES: Immunoglobulin A vasculitis (IgAV), previously known as Henoch–Schönlein purpura, is the most common vasculitis that has a classical skin manifestation of palpable purpuric rash. Factors pertinent to IgAV remain inadequately understood. Here, we aimed to examine the gut microbiome shifts associated with IgAV and its recovery. METHODS: Stool samples were collected from 10 children with IgAV (6–14 years old) before and after a multi‐drug therapy, along with 9 age‐matched healthy children. The samples were subjected to metagenomic analyses to investigate the taxonomic and functional shifts of the gut microbiome. RESULTS: The analyses revealed that compared with healthy controls, treatment‐naïve patients exhibited substantial taxonomic and functional alterations of gut microbiota, including 104 IgAV‐depleted species and 7 IgAV‐elevated species (FDR < 0.05). After treatment, the IgAV patients displayed a partial restoration of the microbiota shifts, as the relative abundances of some biomarkers (e.g. 9 genera and 22 species) became comparable (FDR > 0.1) between the patients and healthy controls. The treatment‐responsive features included Weissella, Faecalibacterium prausnitzii and Bifidobacterium pseudocatenulatum and three components of a putative glutamine transport system. Importantly, gram‐positive bacteria accounted for over 85% of the numbers and total relative abundance of the species that were associated with IgAV and responsive to the treatment. In addition, of the 122 IgAV‐depleted bacterial genes, 82 were mainly contributed by gram‐positive bacteria and 12 by gram‐negative bacteria. CONCLUSIONS: Gram‐positive bacteria are the main drivers underlying the gut microbiome shifts of IgAV, which may assist rational management of the disease. John Wiley and Sons Inc. 2021-10-08 /pmc/articles/PMC8499602/ /pubmed/34646556 http://dx.doi.org/10.1002/cti2.1342 Text en © 2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Short Communication
Cao, Jia
Wu, Chunyan
Wang, Kunhua
Hu, Hongwei
Duan, Jiang
Zhao, Bo
Xiong, Jingjing
Liu, Mei
Cui, Jingjing
Ji, Xiaofei
Zhang, Tingting
Qin, Huanlong
Qin, Nan
Xu, Qian
Huang, Yongkun
Metagenomic profiling reveals dominance of gram‐positive bacteria in the gut microbiome shifts associated with immunoglobulin A vasculitis (Henoch–Schönlein Purpura)
title Metagenomic profiling reveals dominance of gram‐positive bacteria in the gut microbiome shifts associated with immunoglobulin A vasculitis (Henoch–Schönlein Purpura)
title_full Metagenomic profiling reveals dominance of gram‐positive bacteria in the gut microbiome shifts associated with immunoglobulin A vasculitis (Henoch–Schönlein Purpura)
title_fullStr Metagenomic profiling reveals dominance of gram‐positive bacteria in the gut microbiome shifts associated with immunoglobulin A vasculitis (Henoch–Schönlein Purpura)
title_full_unstemmed Metagenomic profiling reveals dominance of gram‐positive bacteria in the gut microbiome shifts associated with immunoglobulin A vasculitis (Henoch–Schönlein Purpura)
title_short Metagenomic profiling reveals dominance of gram‐positive bacteria in the gut microbiome shifts associated with immunoglobulin A vasculitis (Henoch–Schönlein Purpura)
title_sort metagenomic profiling reveals dominance of gram‐positive bacteria in the gut microbiome shifts associated with immunoglobulin a vasculitis (henoch–schönlein purpura)
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499602/
https://www.ncbi.nlm.nih.gov/pubmed/34646556
http://dx.doi.org/10.1002/cti2.1342
work_keys_str_mv AT caojia metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura
AT wuchunyan metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura
AT wangkunhua metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura
AT huhongwei metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura
AT duanjiang metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura
AT zhaobo metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura
AT xiongjingjing metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura
AT liumei metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura
AT cuijingjing metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura
AT jixiaofei metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura
AT zhangtingting metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura
AT qinhuanlong metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura
AT qinnan metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura
AT xuqian metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura
AT huangyongkun metagenomicprofilingrevealsdominanceofgrampositivebacteriainthegutmicrobiomeshiftsassociatedwithimmunoglobulinavasculitishenochschonleinpurpura